Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome.

Anti-Bacterial Agents / adverse effects Bacteria / genetics Bronchiectasis / diagnosis Drug Resistance, Microbial / genetics Humans Microbiota / genetics

Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
30 Jun 2022
Historique:
received: 28 11 2021
accepted: 02 03 2022
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

The development of resistome analysis,

Identifiants

DOI: 10.1183/16000617.0259-2021 PMID: 35613743 PMC: PMC9489181
pubmed: 35613743
pii: 31/164/210259
doi: 10.1183/16000617.0259-2021
pmc: PMC9489181
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©The authors 2022.

Déclaration de conflit d'intérêts

Conflict of interest: P-R. Burgel reports grants or contracts from GSK, Boehringer Ingelheim and Vertex; consulting fees from AstraZeneca, Chiesi, GSK and Insmed; and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Insmed, Novartis, Pfizer, Vertex and Zambon, all outside the submitted work. The remaining authors have nothing to disclose.

Références

Lancet Respir Med. 2013 Oct;1(8):610-620
pubmed: 24461664
Eur Respir J. 2021 Dec 31;59(1):
pubmed: 34667060
J Mol Med (Berl). 2017 Jan;95(1):41-51
pubmed: 27766372
Science. 2009 Aug 28;325(5944):1128-1131
pubmed: 19713526
J Investig Med. 2021 Oct;69(7):1350-1359
pubmed: 34021052
Am J Respir Crit Care Med. 2020 Aug 1;202(3):433-447
pubmed: 32320621
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31611361
Nat Rev Microbiol. 2007 Mar;5(3):175-86
pubmed: 17277795
Expert Rev Mol Diagn. 2019 Apr;19(4):349-362
pubmed: 30895843
Future Microbiol. 2021 Sep;16:1087-1104
pubmed: 34384254
Am J Respir Crit Care Med. 2019 Aug 1;200(3):309-317
pubmed: 30875247
Sci Rep. 2019 Feb 22;9(1):2534
pubmed: 30796252
mSphere. 2018 Apr 18;3(2):
pubmed: 29669883
Lancet. 2014 Aug 23;384(9944):703-13
pubmed: 25152272
PLoS One. 2012;7(9):e45001
pubmed: 23049765
Front Microbiol. 2019 Feb 26;10:212
pubmed: 30863369
Int J Mol Sci. 2017 Jul 29;18(8):
pubmed: 28758937
Cochrane Database Syst Rev. 2018 Oct 30;10:CD009764
pubmed: 30376188
Microbiome. 2017 Feb 10;5(1):20
pubmed: 28187782
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65
pubmed: 22878278
Int J Antimicrob Agents. 2016 Feb;47(2):140-5
pubmed: 26774156
Nucleic Acids Res. 2017 May 5;45(8):e61
pubmed: 28062856
Am J Respir Crit Care Med. 2013 Apr 1;187(7):680-9
pubmed: 23540878
Thorax. 2020 Sep;75(9):780-790
pubmed: 32631930
J Antimicrob Chemother. 2011 Nov;66(11):2448-54
pubmed: 21816767
BMC Microbiol. 2017 May 10;17(1):109
pubmed: 28486933
Cell Rep. 2019 Apr 23;27(4):1190-1204.e3
pubmed: 31018133
Cochrane Database Syst Rev. 2015 Jul 14;(7):CD010337
pubmed: 26171905
Cochrane Database Syst Rev. 2012 Nov 14;11:CD002203
pubmed: 23152214
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14
pubmed: 22451929
Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):30
pubmed: 30151191
ISME J. 2016 May;10(5):1081-91
pubmed: 26555248
Eur Respir J. 2017 Sep 9;50(3):
pubmed: 28889110
Ann N Y Acad Sci. 2017 Jan;1388(1):92-107
pubmed: 27768822
J Cyst Fibros. 2019 Nov;18(6):829-837
pubmed: 30857926
Nat Rev Microbiol. 2017 May;15(5):259-270
pubmed: 28316330
Lancet Respir Med. 2019 Oct;7(10):907-920
pubmed: 30975495
Front Cell Infect Microbiol. 2020 May 14;10:213
pubmed: 32477966
BMJ Open Respir Res. 2018 Sep 23;5(1):e000321
pubmed: 30271606
Thorax. 2014 Jul;69(7):673-4
pubmed: 24287164
Eur Respir J. 2012 Feb;39(2):242-5
pubmed: 22298612
Lancet Respir Med. 2014 Dec;2(12):988-96
pubmed: 25458200
J Clin Microbiol. 2014 Aug;52(8):2813-23
pubmed: 24850358
Front Microbiol. 2018 May 01;9:856
pubmed: 29765367
Int Forum Allergy Rhinol. 2015 Sep;5 Suppl 1:S2-6
pubmed: 26335832
J Cyst Fibros. 2019 Mar;18(2):236-243
pubmed: 30709744
Mayo Clin Proc. 2018 Oct;93(10):1488-1502
pubmed: 30286833
mSphere. 2020 Apr 29;5(2):
pubmed: 32350096
Antimicrob Resist Infect Control. 2020 Jul 28;9(1):116
pubmed: 32723393
Int J Biochem Cell Biol. 2011 Sep;43(9):1241-6
pubmed: 21635965
Lancet. 2017 Aug 12;390(10095):659-668
pubmed: 28687413
Respir Med. 2013 Jul;107(7):1008-13
pubmed: 23683772
Antimicrob Agents Chemother. 2010 Jul;54(7):2823-9
pubmed: 20404127
EMBO Mol Med. 2020 Mar 6;12(3):e10264
pubmed: 32048461
Eur Respir J. 2014 Feb;43(2):343-73
pubmed: 24337046
Microbiome. 2013 Nov 01;1(1):27
pubmed: 24451123
Int J Chron Obstruct Pulmon Dis. 2015 Sep 14;10:1935-49
pubmed: 26392769
Thorax. 2020 Jan;75(1):8-16
pubmed: 31699806
Front Microbiol. 2014 Apr 22;5:178
pubmed: 24795709
J Antimicrob Chemother. 2017 Oct 1;72(10):2690-2703
pubmed: 28673041
Eur Respir J. 2014 Oct;44(4):922-30
pubmed: 25034564
J Cyst Fibros. 2018 Mar;17(2):153-178
pubmed: 29506920
J Clin Microbiol. 2014 Feb;52(2):425-37
pubmed: 24478471
Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2275-85
pubmed: 26363637
Clin Microbiol Infect. 2021 Nov;27(11):1631-1637
pubmed: 34015532
Am J Respir Cell Mol Biol. 2020 Mar;62(3):283-299
pubmed: 31661299
J Cyst Fibros. 2012 Jul;11(4):288-92
pubmed: 22436723
Thorax. 2020 Dec;75(12):1058-1064
pubmed: 33139451
Nat Microbiol. 2019 Jan;4(1):112-123
pubmed: 30478291
Ann Am Thorac Soc. 2021 Feb;18(2):266-272
pubmed: 32810412
Antimicrob Agents Chemother. 2011 Feb;55(2):631-6
pubmed: 21115784
Future Microbiol. 2012 Jan;7(1):73-89
pubmed: 22191448
Med Sci (Paris). 2015 Nov;31(11):947-50
pubmed: 26576596
BMJ. 2019 Jul 29;366:l4486
pubmed: 31358491
Thorax. 2015 Oct;70(10):930-8
pubmed: 26179246
Lancet Respir Med. 2016 Aug;4(8):627-635
pubmed: 27180018
Nat Rev Microbiol. 2017 Jul;15(7):422-434
pubmed: 28392565
J Pediatr. 2017 Feb;181S:S4-S15.e1
pubmed: 28129811
Med J Aust. 2018 Aug 20;209(4):177-183
pubmed: 30107772
Environ Microbiol Rep. 2019 Apr;11(2):62-86
pubmed: 30637962
Pediatr Pulmonol. 2010 Nov;45(11):1121-34
pubmed: 20672296
Curr Opin Pulm Med. 2020 Nov;26(6):679-684
pubmed: 32890021
Ann Intensive Care. 2019 Oct 10;9(1):115
pubmed: 31602529
Virulence. 2014 Apr 1;5(3):443-7
pubmed: 24556726
Cochrane Database Syst Rev. 2020 Sep 30;9:CD001912
pubmed: 32997797

Auteurs

Hélène Pailhoriès (H)

Laboratoire de Bactériologie, Institut de Biologie en Santé - PBH, CHU Angers, Angers, France.
HIFIH Laboratory UPRES EA3859, SFR ICAT 4208, Angers University, Angers, France.

Jean-Louis Herrmann (JL)

Université Paris-Saclay, UVSQ, INSERM, Infection and Inflammation, Montigny-le-Bretonneux, France.
AP-HP, Groupe Hospitalo-Universitaire Paris-Saclay, Hôpital Raymond Poincaré, Garches, France.

Lourdes Velo-Suarez (L)

Brest Center for Microbiota Analysis (CBAM), Brest University Hospital, Brest, France.

Claudie Lamoureux (C)

Dept of Bacteriology, Virology, Hospital Hygiene, and Parasitology-Mycology, Brest University Hospital, Brest, France.
Université de Brest, INSERM, EFS, UMR 1078, GGB, Brest, France.

Clémence Beauruelle (C)

Dept of Bacteriology, Virology, Hospital Hygiene, and Parasitology-Mycology, Brest University Hospital, Brest, France.
Université de Brest, INSERM, EFS, UMR 1078, GGB, Brest, France.

Pierre-Régis Burgel (PR)

Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Institut Cochin, INSERM U1016, Paris, France.
ORCID: 0000-0003-0903-9828

Geneviève Héry-Arnaud (G)

Brest Center for Microbiota Analysis (CBAM), Brest University Hospital, Brest, France hery@univ-brest.fr.
Dept of Bacteriology, Virology, Hospital Hygiene, and Parasitology-Mycology, Brest University Hospital, Brest, France.
Université de Brest, INSERM, EFS, UMR 1078, GGB, Brest, France.
ORCID: 0000-0002-2089-3825

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antibiotic resistance in chronic respiratory...
questionsmedicales.fr › Bactéries › Antibiotic resistance in chronic respiratory...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Maladies des bronches › Dilatation des bronches › Antibiotic resistance in chronic respiratory...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Antibiotic resistance in chronic respiratory...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Antibiotic resistance in chronic respiratory...
questionsmedicales.fr › Environnement et santé publique › Environnement › Écosystème › Biodiversité › Biote › Microbiote › Antibiotic resistance in chronic respiratory...